China Medicine Corporation (CHME)
OTCMKTS · Delayed Price · Currency is USD
0.0006
+0.0001 (20.00%)
At close: Aug 13, 2025
China Medicine Market Cap
China Medicine has a market cap or net worth of $14.35 thousand as of September 5, 2025. Its market cap has decreased by -98.80% in one year.
Market Cap
14.35K
Enterprise Value
n/a
Revenue
65.76M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
Market Cap Chart
Since November 30, 2006, China Medicine's market cap has decreased from 18.45M to 14.35K, a decrease of -99.92%. That is a compound annual growth rate of -31.79%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 13, 2025 | 14.35K | -80.00% |
| Dec 24, 2024 | 71.74K | 15.39% |
| Dec 30, 2022 | 62.18K | 1,199.96% |
| Dec 29, 2021 | 4.78K | -98.11% |
| Dec 31, 2020 | 253.49K | -65.81% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 26, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 972.42M |
| Veradigm | 840.66M |
| Elite Pharmaceuticals | 760.21M |
| Tian'an Technology Group | 673.67M |
| Glass House Brands | 576.95M |
| CytoDyn | 401.20M |
| Northwest Biotherapeutics | 387.41M |
| American Oncology Network | 352.23M |